Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation ...
Panome Bio, a leading multi-omics contract research organization, today announced the launch of MassID™, a cloud-based ...
The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...
Discover the critical bioanalytical factors that influence radiopharmaceutical drug development, from assay design to ...
OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a ...
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...
Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.
Scientists have developed a new way to help understand what happens in the body when people consume a plant product and the ...
Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...
A single exposure to a toxic fungicide during pregnancy can increase epigenetic disease risk for 20 subsequent generations.
A newly published study highlights how a quick and simple blood test may help physicians provide a more accurate diagnosis of Alzheimer's disease. Led by Jordi ...
Integrating "Physical Intelligence" to Accelerate Next-Gen Drug Validation and Bio-AX Revolution SANTA CLARA, CA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results